Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opus Genetics (IRD) Cash from Operations (2020 - 2026)

Opus Genetics has reported Cash from Operations over the past 12 years, most recently at 12727000.0 for Q1 2026.

  • Quarterly Cash from Operations fell 41.51% to 12727000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was 38986000.0 through Mar 2026, down 35.11% year-over-year, with the annual reading at 35253000.0 for FY2025, 37.84% down from the prior year.
  • Cash from Operations was 12727000.0 for Q1 2026 at Opus Genetics, down from 9833000.0 in the prior quarter.
  • Over five years, Cash from Operations peaked at 28791000.0 in Q4 2022 and troughed at 12727000.0 in Q1 2026.
  • The 5-year median for Cash from Operations is 5716000.0 (2024), against an average of 3550235.29.
  • Year-over-year, Cash from Operations soared 609.94% in 2022 and then plummeted 837.31% in 2024.
  • A 5-year view of Cash from Operations shows it stood at 28791000.0 in 2022, then tumbled by 84.2% to 4548000.0 in 2023, then crashed by 263.54% to 7438000.0 in 2024, then crashed by 32.2% to 9833000.0 in 2025, then dropped by 29.43% to 12727000.0 in 2026.
  • Per Business Quant, the three most recent readings for IRD's Cash from Operations are 12727000.0 (Q1 2026), 9833000.0 (Q4 2025), and 6157000.0 (Q3 2025).